Episurf Medical (Nasdaq: EPIS B) today announces that results from a clinical study with follow-up of the 30 first patients from nine Swedish clinics show good implant safety and significantly improved patient-reported outcome scores. Follow-ups of the patients are now completed, and the principle investigator will compile the results for submission to a scientific journal. In total, 30 patients are included in the study and the average follow-up time is 55 months (24 – 86 months).
- Home
- About Us
- Publications
- Videos
- FAQ’s
- ACL FAQs
- Torn Meniscus FAQs
- Patellofemoral Pain Syndrome FAQs
- Knee Arthritis FAQs
- Torn Rotator Cuff & Shoulder Impingement Syndrome FAQs
- Torn Labrum FAQs
- Frozen Shoulder FAQs
- Shoulder Replacement FAQs
- Multidirectional Instablility – Atraumatic FAQs
- AC Separation FAQs
- Hip Replacement FAQs
- Ankle Sprains FAQs
- Bunions (Hallux Valgus) FAQs
- Carpal Tunnel Syndrome FAQs
- Morton’s Neuroma FAQs
- Fellowship
- Specialties
- Patient Ed
- Contact Us
William D. Murrell, MD
Thomas B. Evely, DO
Clifford Voigt, MD
Karthikeyan Chinnakkannu, MD
Max N. Seiter, MD
Demetris Delos, MD
Lauren M. Fabian, MD